Oil and Gas Refining and Marketing

GEVO

GEVO released FY2026 Q1 earnings on May 7 After-Market EST: Actual Revenue USD 42.95M (Forecast USD 44.94M), Actual EPS USD -0.0916 (Forecast USD -0.0233)

Gevo Reports Q1 2026 Earnings and Plans Capacity Expansion

Gevo's Q1 Revenue Growth Misses Analyst Expectations

GEVO to Release FY2026 Q1 Earnings on May 7 After-Market EST, Forecast Revenue USD 44.94 M, EPS USD -0.0233

Gevo Adjusts Financing Strategy for ATJ-30 Plant

GEVO released FY2025 earnings on March 5 After-Market EST, actual revenue USD 160.58 M (forecast USD 159.48 M), actual EPS USD -0.1445 (forecast USD -0.14)

GEVO released FY2025 Q4 earnings on March 5 After-Market EST, actual revenue USD 45.35 M (forecast USD 43.52 M), actual EPS USD -0.0266 (forecast USD -0.03)

GEVO to Release FY2025 Q4 Earnings on March 5 After-Market (EST), Forecast Revenue USD 43.52 M, EPS USD -0.03

Gevo Inc. Secures $175 Million Loan to Refinance Debt

GEVO released FY2025 Q3 earnings on November 10 After-Market EST, actual revenue USD 42.71 M (forecast USD 31.37 M), actual EPS USD -0.0341 (forecast USD -0.0632)

GEVO released FY2025 9 Months Earnings on November 10 After-Market EST with actual revenue of USD 115.23 M and EPS of USD -0.1186

Gevo Reports Q3 EBIT Loss of $3.69 Million

GEVO to release FY2025 Q3 earnings on November 10 After-Market EST, forecast revenue USD 31.37 M, EPS USD -0.0632

DOE Extends Conditional Commitment to Gevo Inc Until April 2026

Gevo Inc Reaches Multi-Year Carbon Credit Sales Agreement with BIORECRO

Gevo's Chief Customer Marketing and Brand Officer Reports Disposition of Common Stock

Gevo Reports First Profitable Quarter

Gevo Inc Submits 2024 Annual Report Amendment

Gevo Inc. Releases Presentation on Jet Fuel Demand Increase and SAF Role

GEVO released FY2025 Semi-Annual earnings on August 11 After-Market (EST), actual revenue USD 72.52 M, actual EPS USD -0.0842

InMed Pharmaceuticals

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

Amesite

CN Energy

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

NextNRG

Meiwu Tech

Generation Income Properties

MetaVia

OceanPal

SBIO

GEVX

LABU

HC Wainwright has revised its Q3 2026 earnings forecast for Gevo, Inc. (NASDAQ:GEVO), lowering the expected earnings per share from ($0.04) to ($0.05). The consensus estimate for the full year is ($0.08) per share. Other analysts have also downgraded their ratings, with Wall Street Zen and Zacks Research issuing 'strong sell' ratings. Gevo's stock opened at $1.76, with a market cap of $428.40 million and a negative net margin of 19.38%. Institutional investors hold 35.17% of the stock, and insider selling has been reported.

Market Beat

ALPS Medical Breakthrough

First Trust NYSE Arca Biotech Index Fd

iShares Biotechnology ETF

SPDR S&P Biotech

Tradr 2X Long GEV Daily ETF

Direxion S&P Biotech Bull 3X

Proshares Ultra Nasdaq Biotech

Invesco Biotechnology & Genome ETF

VanEck Biotech ETF

BNP Paribas

HC Wainwright Issues Negative Forecast for Gevo Earnings

Analysts at Northland Securities have lowered their Q2 2026 earnings per share estimate for Gevo, Inc. to ($0.02), down from ($0.01). They maintain an "Outperform" rating with a target price of $3.50. The consensus estimate for Gevo's full-year earnings is ($0.08) per share. Other analysts have issued mixed ratings, with two Buy, one Hold, and two Sell ratings. Gevo's stock opened at $1.76, with a market cap of $428.40 million. Recent insider transactions show significant share sales by company insiders.

What is Northland Securities' Forecast for Gevo Q2 Earnings?

Gevo shares are trading lower after the company reported worse-than-expected Q1 financial results.

benzinga_article

Earnings Watch

GEVO | 8-K: FY2026 Q1 Revenue Misses Estimate at USD 42.95 M

A company has revealed a preliminary agreement with Ara Energy to fund expansion plans at Gevo North Dakota. Additionally, they have received indications of interest for private capital financing for the Alcohol-to-Jet project. The company is making strides towards achieving a $40 million annualized run-rate Non-GAAP Adjusted EBITDA and anticipates $30 million of Non-GAAP Adjusted EBITDA in the year 2026.

Unusual Whales

Gevo Announces First Quarter 2026 Results and Provides Update on Expansion and Alcohol-to-Jet Project

Gevo (GEVO) will announce its earnings results this Thursday after market close. Last quarter, Gevo reported revenues of $45.35 million, a 696% year-on-year increase, beating analysts' expectations. This quarter, revenue is expected to grow 55.3% year-on-year. Analysts have maintained their estimates, but Gevo has missed revenue targets multiple times in the past. The average analyst price target is $5.44, while the current share price is $2.08. Gevo's peers have shown positive results, with share prices in the sector up 5.2% on average over the last month, while Gevo is down 4.1%.

Stock Story

Gevo (GEVO) Reports Earnings Tomorrow: What To Expect

SHEL

SHEH

Green Sky Capital has secured financing for a Sustainable Aviation Fuel (SAF) production facility in Ain Sokhna, Egypt, marking a significant step in the region's SAF industry development. Supported by regional sponsors like Al Mana Holding and Vision Invest, the facility aims to produce up to 200,000 tonnes of biofuels annually, with commercial operations expected by the end of 2027. The project includes a long-term offtake agreement with Shell and is backed by key financial institutions, highlighting its strategic importance for energy transition in the aviation sector.

Zawya

Shell

Shell plc ADRhedged

Ninety One Plc

Shell PLC

Royal Dutch Shell Plc Class B

ZAWYA: Green Sky Capital signs landmark financing for a Sustainable Aviation Fuel facility in Egypt

Gevo, Inc. insider Andrew Shafer sold 5,550 shares at $2.00 each, totaling $11,100, reducing his ownership by 2.01%. Post-sale, he holds 270,823 shares valued at $541,646. This transaction was part of a pre-arranged trading plan. Gevo's stock recently traded at $2.03, with a market cap of $493.05 million. Analysts have mixed ratings on the stock, with a consensus rating of "Hold" and an average price target of $6.58. Gevo reported a quarterly EPS of ($0.02), beating estimates, with revenue of $45.35 million.

Gevo (NASDAQ:GEVO) Insider Andrew Shafer Sells 5,550 Shares

GEVO(GEVO.US)